Sanofi's Viehbacher Interview on Genzyme, Oct. 5, 2010

Loading player, please wait...
  • Info

  • Comments

Oct. 5 (Bloomberg) -- Chris Viehbacher, chief executive officer of Sanofi-Aventis SA discusses the company's $18.5 billion hostile takeover offer for Genzyme Corp. Sanofi, France’s largest drugmaker, made its offer hostile without increasing an Aug. 29 bid that the U.S. biotechnology company spurned as too low after refusing to negotiate. Viehbacher talked yesterday with Bloomberg's Carol Massar. (Source: Bloomberg)


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change